Patent details

EP1830876 Title: USE OF IMIQUIMOD FOR THE TREATMENT OF CUTANEOUS METASTASES DERIVED FROM A BREAST CANCER TUMOR

Basic Information

Publication number:
EP1830876
PCT Application Number:
PCT/US/2005/047467
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058559568
PCT Publication Number:
WO/2006/071997
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF IMIQUIMOD FOR THE TREATMENT OF CUTANEOUS METASTASES DERIVED FROM A BREAST CANCER TUMOR
French Title of Invention:
UTILISATION DE L'IMIQUIMOD POUR LE TRAITEMENT DE METASTASES CUTANEES DÉRIVÉES D'UNE TUMEUR DU CANCER DU SEIN
German Title of Invention:
VERWENDUNG VON IMQUIMOD FÜR DIE BEHANDLUNG VON HAUTMETASTASEN STAMMEND AUS EINEM BRUSTKREBS
SPC Number:

Dates

Filing date:
30/12/2005
Grant date:
08/04/2015
EP Publication Date:
08/04/2015
PCT Publication Date:
06/07/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/09/2007
EP B1 Publication Date:
08/04/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/12/2021
Expiration date:
30/12/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/12/2005
 
 

Name:
Meda AB
Address:
Pipers väg 2A Box 906, 170 09 Solna, Sweden (SE)

Inventor

1

Name:
HENGGE Ulrich, R
Address:
Germany (DE)

2

Name:
BENNINGHOFF Bernd
Address:
Germany (DE)

Priority

Priority Number:
640491 P
Priority Date:
30/12/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/4745;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
14/12/2020
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
ENVOY INTERNATIONAL LIMITED
Filing date Document type Number of pages